مورد إلكتروني

PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories

التفاصيل البيبلوغرافية
العنوان: PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
المؤلفون: Pepe, F, Venetis, K, Cursano, G, Frascarelli, C, Pisapia, P, Vacirca, D, Scimone, C, Rappa, A, Russo, G, Mane, E, Pagni, F, Castellano, I, Troncone, G, De Angelis, C, Curigliano, G, Guerini-Rocco, E, Malapelle, U, Fusco, N
بيانات النشر: Future Medicine country:GB 2024
نوع الوثيقة: Electronic Resource
مستخلص: Introduction:PIK3CA gene mutations occur in approximately 40% of hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancers (MBCs), electing them to targeted therapy. Testing PIK3CA status is complex due to selection of biological specimen and testing method. Materials & methods: This work investigates real-life experience on PIK3CA testing in HR+/HER2- MBC. Clinical, technical and molecular data on PIK3CA testing were collected from two referral laboratories. Additionally, the results of a nationwide PIK3CA survey involving 116 institutions were assessed. Results: Overall, n = 35 MBCs were PIK3CA-mutated, with mutations mostly occurring in exons 9 (n = 19; 51.4%) and 20 (n = 15; 40.5%). The nationwide survey revealed significant variability across laboratories in terms of sampling methodology, technical assessment and clinical report signing healthcare figures for PIK3CA molecular testing in diagnostic routine practice. Conclusion: This study provides insights into the real-world routine of PIK3CA testing in HR+/HER2- MBC and highlights the need for standardization and networking in predictive pathology.
مصطلحات الفهرس: breast cancer, molecular testing, PIK3CA, info:eu-repo/semantics/article
URL: https://hdl.handle.net/10281/463620
info:eu-repo/semantics/altIdentifier/pmid/38440825
info:eu-repo/semantics/altIdentifier/wos/WOS:001179540200001
volume:25
issue:3
firstpage:161
lastpage:169
numberofpages:9
journal:PHARMACOGENOMICS
الإتاحة: Open access content. Open access content
ملاحظة: ELETTRONICO
English
أرقام أخرى: ITBAO oai:boa.unimib.it:10281/463620
10.2217/pgs-2023-0238
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85188761195
1427430873
المصدر المساهم: BICOCCA OPEN ARCH
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1427430873
قاعدة البيانات: OAIster